Viatris Inc.: Schizophrenia trials

The registry lists 28 Schizophrenia studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 11 have results posted.

Phase 2 1Phase 3 13Phase 4 9No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox CapsuleCompletedNCT01053429Results posted
• One-Year Trial Of Oral Ziprasidone In Patients With Metabolic SyndromeTerminatedNCT00748566Phase 4Results posted
• A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With AgitationCompletedNCT00723606Phase 3Results posted
• Treatment of Schizophrenic Patients With ZiprasidoneCompletedNCT00579670Results posted
• Non Interventional Study In Bipolar Disorder And Schizophrenia With ZeldoxCompletedNCT00538629Results posted
• An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical AntipsychoticsCompletedNCT00448630Results posted
• Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To ZiprasidoneCompletedNCT00406315Phase 4Results posted
• Safety And Tolerability Of Ziprasidone In Adolescents With SchizophreniaTerminatedNCT00265382Phase 3Results posted
• Safety And Efficacy Of Ziprasidone In Adolescents With SchizophreniaTerminatedNCT00257192Phase 3Results posted
• Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031CompletedNCT00174447Phase 3Results posted
• Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With SchizophreniaCompletedNCT00139737Phase 3Results posted
• A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic DisordersCompletedNCT00650611Phase 2
• A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective DisorderCompletedNCT00650429Phase 4
• A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic DrugsCompletedNCT00649844Phase 3
• A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic DrugsCompletedNCT00649064Phase 4
• A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic SchizophreniaTerminatedNCT00645515Phase 3
• A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese PatientsCompletedNCT00645372Phase 3
• A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective DisorderTerminatedNCT00645229Phase 3
• A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of PsychosisCompletedNCT00644800Phase 4
• A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsCompletedNCT00634348Phase 4
• Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and OverweightCompletedNCT00584519
• Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.CompletedNCT00239109Phase 4
• Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic PatientsCompletedNCT00159770Phase 3
• 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic PatientsTerminatedNCT00159757Phase 4
• Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind StudyCompletedNCT00145444Phase 3
• Mozart Relapse StudyCompletedNCT00143351Phase 3
• Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective DisorderCompletedNCT00137020Phase 4
• IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)CompletedNCT00136994Phase 3